Recent news on Lamivudine-Zidovudine

Strides Arcolab ends JV with US firm  -  May 2, 2007
Business Standard,It has tentative approval for a fixed dose combination of anti-retroviral (ARV) drugs Lamivudine, Zidovudine 150 mg and 300 mg tablets, co-packaged with

Isolated Case of Counterfeit Combivir on the Market  -  Apr 12, 2007
Facts and Comparisons,GlaxoSmithKline is informing health care professionals of an incident of misbranding of Ziagen (abacavir sulfate) as Combivir (lamivudine/zidovudine).

The Top 14 Most Counterfeited Medications  -  Mar 28, 2007
ScienceBlogsTrizivir (abacavir/lamivudine/zidovudine - used in the treatment of HIV). 12. Viagra (sildenafil - you know this one for sure)

Strides gets FDA nod for AIDS drugs  -  Mar 25, 2007
Express Pharma,Strides Arcolab has received tentative approval from the USFDA for Lamivudine/Zidovudine 150 mg/300 mg tablets co-packaged with Nevirapine 200 mg tablets.

FDA Announces Tentative Approval Lamivudine/Zidovudine + Nevirapine  -  Mar 6, 2007
PharmaLive.com (press release),The lamivudine/zidovudine combination is a generic formulation of the FDA approved combination product, Combivir, manufactured by GlaxoSmithKline,

Avexa: trial success creates takeover speculation  -  Mar 22, 2007
Pharmaceutical Business ReviewFixed-dose combinations (FDCs) of NRTIs such as Gilead's Truvada (tenofovir/emtricitabine) and GSK's Combivir (lamivudine/zidovudine) are popular as they

Strides Arcolab receives NDA approval from USFDA  -  Mar 6, 2007
Moneycontrol.com (press release),Strides Arcolab Ltd. today announced that it has received tentative approval from the United States Food and Drug Administration for Lamivudine/Zidovudine

Strides Arcolab receives first NDA approval from USFDA  -  Mar 5, 2007
Equity Bulls,...front the United States Food and Drug Administration for Lamivudine / Zidovudine 150 mg / 300 mg Tablets co-packaged with Nevirapine 200 mg Tablets.

FDA Announces Tentative Approval of Triple Drug Fixed Dose Combination  -  Feb 6, 2007
PharmaLive.com (press release),The recommended regimen for the lamivudine-zidovudine-nevirapine tablet is one pill twice a day following an initial two week treatment with the individual

Indian pharmaceutical companies: innovative HIV drug reformulations  -  Feb 8, 2007
Pharmaceutical Business ReviewThe FDA has tentatively approved new HIV drug co-formulations combining lamivudine, zidovudine (both originally developed by GSK) and nevirapine (by

Clinical Cases in Neurology From Johns Hopkins -- Case 15: When a ...  -  Jan 31, 2007
Medscape (subscription)Medications at the time of presentation included trimethoprim-sulfamethoxazole, atazanavir, tenofovir, valacyclovir, and lamivudine/zidovudine.

Gilead Sciences Announces Fourth Quarter and Full Year 2006 ...  -  Feb 1, 2007
PharmaLive.com (press release),This study compares a once-daily regimen of Viread, Emtriva and Sustiva to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once

FDA Safety Changes: Ortho Evra, Avastin, Trizivir  -  26 Dec 2006
Medscape (subscription)On August 11, the FDA approved safety labeling revisions for abacavir sulfate/lamivudine/zidovudine tablets (Trizivir, made by GlaxoSmithKline) to warn of

96-Week Data From Gilead’s Study 934 Comparing Viread ® and ...  -  26 Dec 2006
Business Wire (press release),Emtriva ® (emtricitabine) and Sustiva ® (efavirenz) to a twice-daily regimen of Combivir ® (lamivudine/zidovudine) with Sustiva once daily.

96-Week Data From Gilead's Study 934 Comparing Viread and Emtriva ...  -  26 Dec 2006
PharmaLive.com (press release),Emtriva(R) (emtricitabine) and Sustiva(R) (efavirenz) to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once daily.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional